Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, ...

A first-time mom was diagnosed with a rare cancer after a routine pregnancy scan. Dolly Chhabria, 37, found out she was ...

A first-time mom was diagnosed with a rare cancer after a routine pregnancy scan. Dolly Chhabria, 37, found out she was ...

BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results ...

As hopeful parents start their reproductive journeys, they may be offered a variety of tests and screenings, which can be ...

Non-invasive prenatal testing (NIPT) has recently expanded to include sex chromosomal aneuploidies (SCAs) and copy number variations (CNVs), as well as the commonly screened trisomies (T21, T18, and ...

The new formula is designed to provide more nutrition than leading brands. Needed's prenatal vitamin is based on clinical data from pregnant women rather than standard RDAs. The supplement offers ...

Further reviews and tests did not indicate any cancers common during pregnancies. Even though kidney cancer is rare in young women, Neas’ family history made Webster pause and conduct a CT scan. The ...

Saliva contains biomarkers that mirror those found in blood, including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α). Periodontal disease causes chronic inflammation that enters the ...

Signs of cervical cancer-causing human papillomavirus (HPV) could be found in menstrual blood, offering a potentially less invasive and more accessible alternative to the often-dreaded pelvic exam.

Large prospective study to evaluate a non-invasive prenatal screening test AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today ...

Cellens, a Boston, MA-based cancer diagnostics startup, has raised a $6.5 million seed round. The company is developing a mechanobiology and AI-driven platform, BioFeel, for non-invasive cancer ...